J M Smith

What J M Smith does

J M Smith Corporation is a privately held pharmaceutical and healthcare products wholesale distributor headquartered in Spartanburg, South Carolina, founded in 1925 by James M. Smith Sr. as a single community pharmacy in Asheville, North Carolina. The company operates as a holding company with three primary business units: Smith Drug Company, a full-line distributor of pharmaceuticals, medical equipment (HME/DME), over-the-counter medicines, gifts, and sundries to pharmacies and long-term care facilities; Integral Rx, a secondary source of affordably priced generic medications for independent pharmacies; and Integral Rx Supplies, a custom pharmacy product supplier providing prescription labels, long-term care forms, pharmacy bags, medication cards, and vials. The company also operates the SafeMeds program, a drug diversion prevention initiative that includes software for tracking opioid purchasing trends, compliance monitoring, and educational components addressing prescription drug abuse across the supply chain.

The company's revenue model is transaction-fee-based across its wholesale distribution streams, with pricing negotiated bilaterally through B2B relationships with pharmacies and long-term care facilities rather than publicly disclosed. It serves a fragmented customer base of independent pharmacies nationwide, supplemented by long-term care facilities, through a direct distribution channel-partner model anchored by Smith Drug Company and Integral Rx. Distribution operations span multiple sites including Spartanburg, Asheville, Carey, Milton, and Paragould. The business is led by Chair and CEO Paula Harper Bethea, with President and COO Wade Lewis overseeing Smith Drug Company, CFO Helen Dowbak (appointed 2020), and a board including former Davis Polk M&A partner John A. Bick. J M Smith is recognized as the third-largest privately held company in South Carolina and remains under family-influenced governance with no disclosed institutional or private-equity ownership.

Name

J M Smith

Legal name

J M Smith Corporation

Website

https://jmsmith.com

Company type

Private

Founded year

1925

Operating status

Operating

Headcount range

101–250 employees

Short description

J M Smith Corporation is a privately held Spartanburg, SC-based holding company that, through Smith Drug Company, Integral Rx, and Integral Rx Supplies, distributes pharmaceuticals, generics, medical equipment, and custom pharmacy products to independent pharmacies and long-term care facilities across the United States.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

akta.pro secondary industry

Pharmaceuticals & Life Sciences Forwarding (GxP/GDP) (TLACAJAB)

Keywords

• Pharmaceutical distribution
• Generic drug distribution
• Pharmacy supplies
• Long-term care pharmacy
• Drug diversion prevention

Headquarters

HQ city

Spartanburg

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution: Full-line distribution of pharmaceuticals, medical equipment (HME/DME), over-the-counter medicines, gifts and sundries to pharmacies and long-term care facilities through Smith Drug Company.
2. Secondary Source Supplies: Secondary source distribution of supplies and generics helping independent pharmacies with affordably priced generic medications through Integral Rx.
3. Custom Pharmacy Products: Custom pharmacy product supplies including prescription labels, long-term care forms, pharmacy bags, medication cards, vials, and other configuration options through Integral Rx Supplies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

J M Smith Corporation operates as a holding company that provides full-line pharmaceutical distribution through Smith Drug Company, secondary-source generic drug distribution through Integral Rx, and custom pharmacy products through Integral Rx Supplies. The company serves independent retail pharmacies and long-term care facilities across the United States, also operating the SafeMeds program for drug diversion prevention.

Product overview

J M Smith Corporation operates as a healthcare services and distribution company with three primary business units: Smith Drug Company (full-line pharmaceutical and medical equipment distributor), Integral Rx (generic pharmaceuticals supplier), and Integral Rx Supplies (custom pharmacy products). The company also offers SafeMeds, a drug diversion prevention program with software capabilities. The portfolio is structured as a holding company model with distinct business units serving independent pharmacies across the United States.

Differentiator

Problem solved

Functional benefit

Brands

• Smith Drug Company: Full-line distributor of pharmaceuticals, medical equipment (HME/DME), over-the-counter medicines, gifts and sundries to pharmacies and long-term care facilities.
• Integral Rx
• Integral Rx Supplies

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators3 records

Recent moves3 records

Expansion highlights5 records

Broad incumbents

• Cencora (formerly AmerisourceBergen): Cencora is one of the Big Three US pharmaceutical distributors, supplying retail, hospital, and specialty pharmacies with branded and specialty products (and it acquired H. D. Smith). Like J M Smith, it is a full-line pharma wholesaler, but at vastly greater scale and with deeper specialty and biologics capability.
• Owens & Minor: Owens & Minor is a national distributor of medical and surgical supplies serving healthcare providers. It is comparable to J M Smith's HME/DME distribution line through Smith Drug Company as a broader-scale medical supplies wholesaler in an overlapping end market.
• Cardinal Health: Cardinal Health is the third member of the US Big Three pharma distributors, distributing pharmaceuticals and medical supplies to retail pharmacies, hospitals, and ambulatory providers. It directly mirrors Smith Drug Company's full-line distribution model and competes for the same independent pharmacy customers.
• McKesson Corporation: McKesson is the largest US pharmaceutical wholesaler, distributing branded, generic, and specialty drugs to pharmacies and health systems nationwide. It is comparable to J M Smith as the dominant scaled counterpart in the same core Rx wholesale category, against which J M Smith competes for independent pharmacy share.

Direct peers

• PharmaPac Inc. PharmaPac is a regional pharmaceutical wholesaler and packaging supplier serving independent pharmacies in the US Southeast and Midwest. It is comparable to both Smith Drug Company's wholesale arm and Integral Rx Supplies' pharmacy packaging business given its overlapping southern customer footprint.
• Rochester Drug Cooperative: Rochester Drug Cooperative is an independent, member-owned pharmaceutical distributor serving independent pharmacies in the Northeast and Mid-Atlantic. It is directly comparable to J M Smith as a co-op/independent-led wholesaler competing for the same independent pharmacy customer base.
• Anda Inc. (Teva Pharmaceutical Industries): Anda is a major US distributor of generic, brand, and specialty pharmaceuticals focused on retail pharmacies, including independents. It is comparable to both Smith Drug Company and Integral Rx given its mix of brand and generic distribution into the same pharmacy channels.
• Morris & Dickson Co., L.L.C. Morris & Dickson is an independently owned, full-line pharmaceutical wholesaler focused on independent retail pharmacies across the US South. It is the closest direct peer to Smith Drug Company in terms of customer type, regional strength, and independent-pharmacy-only focus.
• TopRx: TopRx is a US pharmaceutical distributor and pharmacy services platform serving independent pharmacies with full-line distribution and analytics. It is a direct peer to Smith Drug Company, competing for the same independent pharmacy accounts with a more tech-forward service bundle.

Emerging players

• ClarusONE Sourcing Alliance: ClarusONE is a generic pharmaceutical sourcing joint venture created for independent pharmacy wholesalers. It is directly relevant to J M Smith's Integral Rx business as a competing aggregated generic sourcing channel for independent pharmacy distributors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/j-m-smith-corporation

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about J M Smith